[Nochmar]

We've only received a couple of requests for this indication. My conclusion was the same as the other writers; it is definitely still at the investigational stages, but it seems more likely to provide benefit for LUTS than erectile function. The requests that I have received have not been consistant with the doses used in the clinical trials. At this point, I don't believe there is enough information available to justify coverage. If coverage would be approved, I think we would place a time limit on it to help ensure we stay close to the limitations of our benefit certificate.